ArticleNature biotechnology2014
ProteomeXchange provides globally coordinated proteomics data submission and dissemination.
Abstract readLetter
In one paragraph
Article in Nature biotechnology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1,590 papers, 4 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
1,590citing papers in PubMed, 4 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1,590 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- An AI-Ready Phosphorylation Meta-Analysis forJournal of proteome research · 2026Pooled it
- Properties, Origin, and Consistency of Truncated Proteoforms Across Top-Down Proteomic Studies.Molecular & cellular proteomics : MCP · 2025Pooled it
- Phosphorylation in theJournal of proteome research · 2024Pooled it
- Meta-Analysis of Rice Phosphoproteomics Data to Understand Variation in Cell Signaling Across the Rice Pan-Genome.Journal of proteome research · 2024Pooled it
- Proteomic Profiling of Xenobiotic and Nutrient Transporters in Human Placenta of Different Gestational Ages.Clinical pharmacology and therapeutics · 2026Article
- ThermoTargetMiner as a proteome integral solubility alteration target database for prospective drugs against lung cancer.Communications chemistry · 2026Article
- Omics data discovery agents: Agent-supported retrieval, reanalysis, and synthesis of published omics data.PLoS computational biology · 2026Article
- Establishment of Uveal Melanoma Patient-Derived Organoids Using an Air-Liquid Interface System for Translational Research.Investigative ophthalmology & visual science · 2026Article
- Integrative analysis of cadmium exposure and osteoarthritis: from population evidence to molecular mechanisms.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
- Review
- Therapy induced senescence promotes immunogenicity in acute myeloid Leukemia through reduced EZH2 activity.Nature communications · 2026Article
- The insulin/IGF axis is critically important for controlling gene transcription in the podocyte.eLife · 2026Article
- Engineering editopes through programmable RNA editing toward tumor neoantigen generation.The EMBO journal · 2026Article
- Proteomic Insights Into Human Induced Regulatory T Cells: The Role of LPXN and CD160 in Immune Suppression.Molecular & cellular proteomics : MCP · 2026Article
- Surface-Enhanced Raman Spectroscopy for Viral Diagnostics: Principles, Strategies, Clinical Challenges, and Future Directions.Chemical reviews · 2026Review
- Sex-Dependent Responses in the Retina Proteome to Ocular Hypertension in a Mouse Model of Glaucoma.International journal of molecular sciences · 2026Article
- Bypassing Androgens: Retina-Targeted 17β-Estradiol Delivery via DHED Eye Drops Ameliorates Orchiectomy-Induced Shifts in the Male Rat Visual Cortex Proteome.Antioxidants (Basel, Switzerland) · 2026Article
- PI3K Regulates Wild-type RAS Signaling to Confer Resistance to KRAS Inhibition.Cancer research · 2026Article
- Scalable phosphotyrosine enrichment with SH2 superbinder enables deep profiling of EGF responses.The EMBO journal · 2026Article
- Fractionated proteomics identifies a protein network mitigating resistance exercise-induced damage in human skeletal muscle.Nature communications · 2026Article
1,530 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors.
Juan A Vizcaíno1] European Molecular Biology Laboratory, European Bioinformatics Institute (EMBLEBI), Wellcome Trust Genome Campus, Hinxton, Cambridge, UK. [2].
Eric W Deutsch1] Institute for Systems Biology, Seattle, Washington, USA. [2].
Rui WangEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBLEBI), Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
Attila CsordasEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBLEBI), Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
Florian ReisingerEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBLEBI), Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
Daniel RíosEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBLEBI), Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
José A DianesEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBLEBI), Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
Zhi SunInstitute for Systems Biology, Seattle, Washington, USA.
Terry FarrahInstitute for Systems Biology, Seattle, Washington, USA.
Nuno BandeiraCenter for Computational Mass Spectrometry, University of California, San Diego, La Jolla, California, USA.
Pierre-Alain BinzSwiss-Prot Group, SIB Swiss Institute of Bioinformatics, Geneva, Switzerland.
Ioannis Xenarios1] Swiss-Prot Group, SIB Swiss Institute of Bioinformatics, Geneva, Switzerland. [2] University of Lausanne, Lausanne, Switzerland, and Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland. [3] Vital-IT Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Martin EisenacherMedizinisches Proteom-Center, Ruhr-Universität Bochum, Bochum, Germany.
Gerhard MayerMedizinisches Proteom-Center, Ruhr-Universität Bochum, Bochum, Germany.
Laurent GattoComputational Proteomics Unit and Cambridge Centre for Proteomics, Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom.ORCID 0000000215202268
Alex CamposIntegromics SL, Santiago Grisolia, Madrid, Spain.
Robert J ChalkleyDepartment of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California, USA.
Hans-Joachim KrausWiley-VCH Verlag, Weinheim, Germany.
Juan Pablo AlbarProteoRed-ISCIII, National Center for Biotechnology-CSIC, Madrid, Spain.
Salvador Martinez-BartoloméProteoRed-ISCIII, National Center for Biotechnology-CSIC, Madrid, Spain.
Rolf ApweilerEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBLEBI), Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
Gilbert S Omenn1] Institute for Systems Biology, Seattle, Washington, USA. [2] Center for Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan, USA.
Lennart Martens1] Department of Medical Protein Research, VIB, Ghent, Belgium. [2] Department of Biochemistry, Ghent University, Ghent, Belgium.ORCID 000000034277658X
Andrew R JonesInstitute of Integrative Biology, University of Liverpool, UK.
Henning HermjakobEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBLEBI), Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
Funding
MICHIGAN INSTITUTE FOR CLINICAL AND HEALTH RESEARCH (MICHR) (UL1): (BPCA)UL1RR024986 · NCRR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHANLEY, THOMAS P. · 2007 to 2011
$51.2MStrategic Vision & Impact on Environmental HealthP30ES017885 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Dana Dolinoy · 2011 to 2026
$21.3MTrainingP41GM103484 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BAFNA, VINEET, BANDEIRA, NUNO · 2012 to 2018
$8.7MBio-Organic Biomedical Mass Spectromy ResourceP41GM103481 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BURLINGAME, ALMA L · 2012 to 2015
$6.4MShortening the development cycle time of Trans Proteomic Pipeline tools with high performance computingR01GM087221 · NIGMS · INSTITUTE FOR SYSTEMS BIOLOGY · PI DEUTSCH, ERIC, MORITZ, ROBERT L · 2010 to 2021
$6.0MBiotechnology and Biological Sciences Research Council BB/I00095X/1Biotechnology and Biological Sciences Research Council BB/I024204/1NCRR NIH HHS UL1RR24986NIEHS NIH HHS P30U54ES017885NIGMS NIH HHS P41 GM103481NIGMS NIH HHS P41 GM103484NIGMS NIH HHS R01 GM087221Wellcome Trust 085949Wellcome Trust WT085949MA
Abstract
PubMed holds no abstract for this paper.
Indexed as
Database Management SystemsDatabases, ProteinInternetMass SpectrometryProteomicsSoftwareAnimalsHumansInternational CooperationMice
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.